AHA Expresses Strong Support of the 340B Drug Pricing Program

AHA expresses strong support for the 340B Drug Pricing Program. Hospitals are committed to ensuring that the 340B program can continue to fulfill its original intent of helping providers stretch limited resources to expand and improve access to comprehensive health care services for patients and communities. The increasingly high cost of pharmaceuticals continues to underscore the importance of the 340B program in helping achieve this goal. View the entire letter under key resources.